- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
UnitedHealth CEO Expresses Regret at ACA Participation
Entering into the Affordable Care Act health insurance marketplaces was a bad decision, according to the CEO of UnitedHealth Group Inc, which is considering pulling back from participation in 2017.
Entering into the Affordable Care Act (ACA) health insurance marketplaces was a bad decision for UnitedHealth Group Inc, according to its CEO.
Bloomberg Business reported that Stephen Hemsley told investors at a meeting in New York, that the company should have stayed out of the marketplaces longer. On November 19, the company announced that it was taking heavy losses as a result of its marketplace involvement and that it was considering no longer selling plans through the ACA in 2017.
“It was for us a bad decision,” Hemsley said, adding, “In retrospect, we should have stayed out longer.”
There are approximately 500,000 UnitedHealth customers on the exchanges. Other insurers have noted weak enrollment, which will take a toll on their profits, reported Reuters, but so far UnitedHealth is the only company to announce it may depart from the exchanges as a result.
As Hemsley explained during the investors meeting, the company will analyze during 2016 the products it offers and regions where it sells plans to determine where it could exit.
However, Hemsley did acknowledge that the problems were not necessarily a result of the exchanges and could be a UnitedHealth issue. Reuters further reported that a pullback from the exchanges could only be temporary, which wouldn’t be unheard of from the company, which also withdrew from Medicare Advantage and Medicaid before re-entering them later.
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
